Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study.

Simon, Dagmar; Yousefi, Shida; Cazzaniga, Simone; Bürgler, Christina; Radonjic, Susanne; Houriet, Carine; Heidemeyer, Kristine; Klötgen, Hans-Willhelm; Kozlowski, Evelyne; Borradori, Luca; Simon, Hans-Uwe (2020). Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study. Allergy, 75(3), pp. 669-672. Wiley 10.1111/all.13950

[img]
Preview
Text
Simon_et_al-2019-Allergy.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (322kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

09 Interdisciplinary Units > Microscopy Imaging Center (MIC)
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Simon, Dagmar; Yousefi, Shida; Cazzaniga, Simone; Bürgler, Christina; Radonjic, Susanne Irene; Houriet, Carine; Heidemeyer, Kristine; Klötgen, Hans-Willhelm; Kozlowski, Eveline; Borradori, Luca and Simon, Hans-Uwe

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1398-9995

Publisher:

Wiley

Language:

English

Submitter:

Celine Joray

Date Deposited:

07 Aug 2019 07:47

Last Modified:

01 Dec 2020 15:51

Publisher DOI:

10.1111/all.13950

PubMed ID:

31230371

BORIS DOI:

10.7892/boris.132368

URI:

https://boris.unibe.ch/id/eprint/132368

Actions (login required)

Edit item Edit item
Provide Feedback